ZNF524 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.665600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.016800E-01
Normal-vs-Stage2
7.119400E-01
Normal-vs-Stage3
8.707200E-01
Normal-vs-Stage4
2.685400E-01
Stage1-vs-Stage2
5.034000E-01
Stage1-vs-Stage3
3.367400E-01
Stage1-vs-Stage4
5.336600E-01
Stage2-vs-Stage3
5.569400E-01
Stage2-vs-Stage4
1.448790E-01
Stage3-vs-Stage4
2.422000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.716000E-01
Normal-vs-AfricanAmerican
7.519800E-01
Normal-vs-Asian
1.039050E-01
Caucasian-vs-AfricanAmerican
9.727800E-01
Caucasian-vs-Asian
1.497980E-01
AfricanAmerican-vs-Asian
2.947200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.337200E-01
Normal-vs-Female
7.340000E-01
Male-vs-Female
1.990410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.121600E-01
Normal-vs-Age(41-60Yrs)
8.577800E-01
Normal-vs-Age(61-80Yrs)
6.283200E-01
Normal-vs-Age(81-100Yrs)
3.730400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.939400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.036800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.376400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.007600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.862350E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.848400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.183200E-01
Normal-vs-Daily Drinker
2.200200E-01
Normal-vs-Weekly Drinker
2.150600E-01
Normal-vs-Occasional Drinker
4.161600E-01
Normal-vs-Social Drinker
8.000000E-01
Non Drinker-vs-Daily Drinker
2.762200E-02
Non Drinker-vs-Weekly Drinker
3.591400E-01
Non Drinker-vs-Occasional Drinker
2.668600E-01
Non Drinker-vs-Social Drinker
1.661830E-01
Daily Drinker-vs-Weekly Drinker
9.725000E-01
Daily Drinker-vs-Occasional Drinker
4.040800E-01
Daily Drinker-vs-Social Drinker
6.520600E-03
Weekly Drinker-vs-Occasional Drinker
6.499600E-01
Weekly Drinker-vs-Social Drinker
1.729050E-01
Occasional Drinker-vs-Social Drinker
5.693500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.162400E-01
Normal-vs-Grade 2
2.066200E-01
Normal-vs-Grade 3
1.491640E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.937600E-01
Grade 1-vs-Grade 3
8.361400E-01
Grade 1-vs-Grade 4
3.162400E-01
Grade 2-vs-Grade 3
7.621000E-01
Grade 2-vs-Grade 4
2.066200E-01
Grade 3-vs-Grade 4
1.491640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.651400E-01
Normal-vs-NonDiabetic
5.264400E-01
Diabetic-vs-NonDiabetic
4.361200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.914000E-01
Normal-vs-NoPancreatitis
6.243400E-01
Pancreatitis-vs-NoPancreatitis
2.556600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.354200E-01
Normal-vs-N1
7.859400E-01
N0-vs-N1
9.923600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.106300E-02
Normal-vs-TP53-NonMutant
4.437200E-01
TP53-Mutant-vs-TP53-NonMutant
1.112440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
